ZERINI, DARIO
 Distribuzione geografica
Continente #
EU - Europa 2.196
NA - Nord America 1.621
AS - Asia 1.552
Continente sconosciuto - Info sul continente non disponibili 141
SA - Sud America 139
AF - Africa 39
OC - Oceania 9
Totale 5.697
Nazione #
US - Stati Uniti d'America 1.561
DE - Germania 1.037
IT - Italia 483
SG - Singapore 390
CN - Cina 387
BD - Bangladesh 298
HK - Hong Kong 159
GB - Regno Unito 153
SE - Svezia 145
VN - Vietnam 130
RU - Federazione Russa 125
BR - Brasile 101
IN - India 64
FR - Francia 62
NL - Olanda 48
CA - Canada 42
IE - Irlanda 38
JP - Giappone 27
PH - Filippine 24
CI - Costa d'Avorio 19
DK - Danimarca 19
FI - Finlandia 19
TR - Turchia 15
PL - Polonia 13
ID - Indonesia 11
AR - Argentina 10
BE - Belgio 10
KR - Corea 10
AU - Australia 9
CH - Svizzera 9
EC - Ecuador 8
ES - Italia 8
ZA - Sudafrica 8
AT - Austria 7
CL - Cile 6
MX - Messico 5
PK - Pakistan 5
IQ - Iraq 4
KE - Kenya 4
UY - Uruguay 4
CR - Costa Rica 3
HN - Honduras 3
KZ - Kazakistan 3
MY - Malesia 3
PE - Perù 3
PY - Paraguay 3
RO - Romania 3
TW - Taiwan 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
CO - Colombia 2
DO - Repubblica Dominicana 2
EU - Europa 2
IR - Iran 2
JM - Giamaica 2
LT - Lituania 2
MA - Marocco 2
PT - Portogallo 2
ST - Sao Tome e Principe 2
TH - Thailandia 2
AO - Angola 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 5.558
Città #
Frankfurt am Main 951
Ashburn 263
Singapore 216
Chandler 139
Hong Kong 137
Milan 133
San Jose 125
Southend 117
Dallas 113
Beijing 69
Council Bluffs 63
Los Angeles 61
New York 53
Santa Clara 51
Houston 46
Ho Chi Minh City 45
Rome 42
Dublin 38
Princeton 38
Hanoi 36
Ann Arbor 33
Hefei 32
Seattle 30
Buffalo 29
Wilmington 29
Fairfield 26
Munich 24
Moscow 23
Phoenix 23
Bengaluru 20
Lauterbourg 20
Naples 20
Abidjan 19
Boardman 19
Shanghai 19
Tokyo 19
Cambridge 18
Guangzhou 16
Helsinki 15
São Paulo 15
Turin 15
Toronto 14
Columbus 13
Des Moines 12
Florence 12
Istanbul 12
Woodbridge 12
Brussels 10
Jinan 10
London 10
Warsaw 10
Dearborn 9
Hyderabad 9
Seoul 9
Cangzhou 8
Falls Church 8
Grafing 8
Montreal 8
Berlin 7
Cagliari 7
Jakarta 7
Bologna 6
Catania 6
Da Nang 6
Düsseldorf 6
Fremont 6
Mumbai 6
Nanjing 6
Orem 6
Pavia 6
Shenyang 6
The Dalles 6
Zurich 6
Bari 5
Central District 5
Chicago 5
Denver 5
Haiphong 5
Johannesburg 5
Menlo Park 5
Portland 5
Quanzhou 5
Santiago 5
Shenzhen 5
Wuhan 5
Amsterdam 4
Atlanta 4
Boston 4
Buenos Aires 4
Cao Lanh 4
Chennai 4
Dhaka 4
Genoa 4
Guayaquil 4
Hammersmith 4
Mannheim 4
Medford 4
Nagold 4
Nanchang 4
Nuremberg 4
Totale 3.587
Nome #
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 433
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218) 322
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 319
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 310
[11C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy 309
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach 302
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 256
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 249
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer 246
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome 245
Mixed-beam approach for high-risk prostate cancer : Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300) 241
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial 237
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases 226
Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience 217
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion : a plan comparison 215
Erratum: Correction to: Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation (La Radiologia medica (2019) 124 1 (65-78)) 207
Clinical outcomes and radio-biological features correlation in early pca: An exploratory analysis 204
Oligo metastatic renal cell carcinoma : stereotactic body radiation therapy, if, when and how? 199
Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer : A Propensity Score Analysis 198
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation : results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 191
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus 174
Cyberknife Radiosurgery for Prostate Cancer after Abdominoperineal Resection (CYRANO): The Combined Computer Tomography and Electromagnetic Navigation Guided Transperineal Fiducial Markers Implantation Technique 143
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis 132
Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available? 122
Totale 5.697
Categoria #
all - tutte 13.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022321 0 17 11 16 30 31 12 27 28 34 32 83
2022/2023431 60 62 49 40 33 82 9 28 38 0 24 6
2023/2024856 12 17 23 16 79 37 141 106 57 108 141 119
2024/2025963 135 110 103 115 67 26 16 61 41 75 74 140
2025/20262.267 244 183 222 189 166 104 301 54 159 137 301 207
2026/2027287 145 142 0 0 0 0 0 0 0 0 0 0
Totale 5.697